ArticleCellular oncology (Dordrecht, Netherlands)2024

SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.

Lucía Gutiérrez-Chamorro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.